<DOC>
	<DOC>NCT01605851</DOC>
	<brief_summary>The primary objective of this study is to evaluate clinical success and performance of the GORE® Septal Occluder when used for percutaneous, transcatheter closure of Patent Foramen Ovale (PFO).</brief_summary>
	<brief_title>GORE® Septal Occluder European Union Clinical Evaluation</brief_title>
	<detailed_description />
	<criteria>Subjects with a PFO less than or equal to 17mm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>PFO</keyword>
	<keyword>closure</keyword>
</DOC>